Overview

Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)

Status:
Not yet recruiting

Trial end date:
2022-05-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and compliance of initial intravenous (IV) antibiotics followed by oral antibiotic therapy following uncomplicated IVDA endocarditis. Endocarditis has a high rate of sickness and death, involves a long hospitalization and a long-term use of IV antibiotics necessitating six (6) weeks of in-patient hospital stay, and comes with a high cost.

Phase:

Phase 4

Details

Lead Sponsor:

Vinay Badhwar

Treatments:

Amoxicillin
Ampicillin
Cefepime
Ceftaroline fosamil
Ceftriaxone
Cephalexin
Daptomycin
Dicloxacillin
Levofloxacin
Linezolid
Oxacillin
Rifampin
Vancomycin